Myogen
Westminster
About Myogen
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $191.8M
- Funding stage: M&A
- Last round: Series D (Aug 2003)
- Ticker: nasdaq:MYOG
- Website: myogen.com
- Phone: +1 303-464-5222
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/myogen-832976 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.